publication . Article . 2020

Bee Venom—A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections

Keneth Iceland Kasozi; Keneth Iceland Kasozi; Gniewko Niedbała; Mohammed Alqarni; Gerald Zirintunda; Fred Ssempijja; Simon Peter Musinguzi; Ibe Michael Usman; Kevin Matama; Helal F. Hetta; ...
Open Access English
  • Published: 10 Dec 2020 Journal: Frontiers in Public Health, volume 8 (issn: 2296-2565, Copyright policy)
  • Publisher: Frontiers Media S.A.
  • Country: United Kingdom
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by severe cytokine storm syndrome following inflammation. SARS-CoV-2 directly interacts with angiotensin-converting enzyme 2 (ACE-2) receptors in the human body. Complementary therapies that impact on expression of IgE and IgG antibodies, including administration of bee venom (BV), have efficacy in the management of arthritis, and Parkinson's disease. A recent epidemiological study in China showed that local beekeepers have a level of immunity against SARS-CoV-2 with and without previous exposure to virus. BV anti-inflammatory properties are associated with melittin and phospholipase A...
free text keywords: bee venom, complementary medicine and alternative medicine, SARS-CoV-2 (2019-nCoV), pharmokinetics of bee poison, COVID-19 and complementary medicine, bee venom in clinical trials, Public Health, Environmental and Occupational Health, Public Health, Review, lcsh:Public aspects of medicine, lcsh:RA1-1270, Antibody, biology.protein, biology, Cytokine storm, medicine.disease, medicine, Virus, Proinflammatory cytokine, Immunity, business.industry, business, Immune system, Interferon, medicine.drug, Tumor necrosis factor alpha, Immunology
Related Organizations
Any information missing or wrong?Report an Issue